Insider Buying: Champions Oncology Inc (CSBR) President Acquires 9,537 Shares of Stock
Champions Oncology Inc (OTCMKTS:CSBR) President Ronnie Morris purchased 9,537 shares of the firm’s stock in a transaction that occurred on Monday, October 10th. The shares were bought at an average price of $1.66 per share, for a total transaction of $15,831.42. Following the acquisition, the president now directly owns 1,026,347 shares in the company, valued at approximately $1,703,736.02. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Ronnie Morris also recently made the following trade(s):
- On Tuesday, September 20th, Ronnie Morris purchased 3,000 shares of Champions Oncology stock. The shares were bought at an average price of $1.58 per share, for a total transaction of $4,740.00.
Champions Oncology Inc (OTCMKTS:CSBR) traded up 0.60% during mid-day trading on Tuesday, reaching $1.67. The company had a trading volume of 28,114 shares. Champions Oncology Inc has a 52 week low of $1.11 and a 52 week high of $5.49. The stock’s market capitalization is $18.31 million. The stock has a 50 day moving average of $1.68 and a 200 day moving average of $2.58.
Champions Oncology (OTCMKTS:CSBR) last posted its earnings results on Friday, September 9th. The company reported ($0.15) EPS for the quarter. The company earned $3.70 million during the quarter.
Champions Oncology Company Profile
Champions Oncology, Inc is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans.
Receive News & Stock Ratings for Champions Oncology Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Champions Oncology Inc and related stocks with our FREE daily email newsletter.